A
AKTX
Akari Therapeutics Plc
13.40
-1.42-9.58%After Hours: 13.66 +0.26 +1.94%19:17 06/12 EDT
OPEN/PREV CLOSE14.23/14.82
TODAY RANGE13.31-15.72
VOL112.89K
MARKET CAP21.10M
52 WEEK RANGE3.015-52.00
AVG VOL (3M)769.71K
% TURNOVER7.17%
TURNOVER--
P/E (TTM)-0.0316
% RANGE16.26%
EPS(TTM)-424.4800
P/E(FORWARD)-4.6447
P/B-0.5103
BVPS-0.5520
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP17.33M
SHARES OUTSTANDING1.57M
NEXT EARNINGS08/11-08/17
FREE FLOAT1.29M
LOT SIZE1
EX-DATE03/31/2026
News
Press Releases
Financial Reports
Profile
TipRanks·12h ago
Seven new option listings and one option delisting on June 12th
Benzinga·05/29 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·05/28 17:06
Akari Therapeutics trading resumes
Benzinga·05/28 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
TipRanks·05/28 13:56
Akari Therapeutics trading halted, volatility trading pause
Benzinga·05/26 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·05/26 16:51
Akari Therapeutics trading halted, volatility trading pause
TipRanks·05/26 16:45
Akari Therapeutics trading resumes
TipRanks·05/26 14:40
3 Penny Stocks to Watch Now, 5/26/26
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.